Stay updated on KX2-361 Safety & PK in Refractory Malignancies Clinical Trial
Sign up to get notified when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.

Latest updates to the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedA new revision stamp Revision: v3.5.3 has been added, replacing the previous Revision: v3.5.2. This reflects a software release update shown on the page's footer.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2, indicating a software version update. This change does not alter study information or page content.SummaryDifference0.1%

- Check50 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page now shows Revision: v3.4.2. The prior Revision: v3.4.1 notice and the government funding lapse notice have been removed.SummaryDifference0.5%

- Check93 days agoChange DetectedAdded a government funding lapse notice on the page informing users that information may not be up to date and actions may be delayed. Updated the system revision to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

Stay in the know with updates to KX2-361 Safety & PK in Refractory Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.